Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

THE TRUTH ABOUT: 2 | History Defined

Intuitive Surgical Reveals New FDA-Cleared Features Driving Innovation In da Vinci 5

On Friday, Intuitive Surgical Inc. (NASDAQ:ISRG) unveiled the first set of new software capabilities for its da Vinci 5 surgical system, which is aimed at boosting surgeon performance and hospital efficiency.

Benzinga

Ashes to Alpha: Why Intuitive Surgical’s (ISRG) Fallout is a Legit Upside Opportunity

With concerns that the Trump administration’s tariffs could impact Intuitive Surgical’s business, ISRG stock tumbled on Wednesday, presenting a contrarian prospect.

Barchart

Is Intuitive Surgical Stock Underperforming the S&P 500?

Whereas Intuitive Surgical has delivered weaker returns than the S&P 500 Index over the past year, analysts are moderately optimistic about the stock’s prospects.

Barchart

From analysis to the latest developments in health,
read the most diverse news in one place.

3 Robotics Stocks at the Heart of the Robotics Revolution

Robotics is a logical extension of the AI revolution, these three robotics stocks bring AI-driven growth to healthcare, logistics, and enterprise software

MarketBeat

One Buy-Rated Stock With an Unbreakable Moat That You Can’t Ignore

Intuitive Surgical is one of those rare companies with an unshakeable moat.

Barchart

Intuitive Surgical Crushes Q2 Expectations, So Why No Rally?

Robotics healthcare giant Intuitive Surgical handily beat expectations in Q2. Shares stayed flat; the bullish long-term outlook for this stock rides on.

MarketBeat

Intuitive Surgical Beats Q2 Earnings Estimates As Revenue Jumps 21%, Shares Slide

Intuitive Surgical Inc (NASDAQ:ISRG) reported financial results for the second quarter after the market close on Tuesday. Here’s a look at hey metrics from the quarter.

Benzinga

Read news from The Economist, FT, and more,
with one subscription

5 Robotics Stocks to Buy for the Future of Automation

Robotics adoption is accelerating globally, with AI, automation, and real-time data processing reshaping industries from healthcare to manufacturing.

MarketBeat

What to Expect From Intuitive Surgical's Next Quarterly Earnings Report

Intuitive Surgical is set to release its second-quarter results next month, with analysts projecting single-digit growth in earnings.

Barchart

Intuitive Surgical: Profit or Peril Ahead Amid Trade & Turf Wars?

Intuitive Surgical has soared over 150% in three years. But, can the healthcare stalwart overcome tariffs and rising competition to continue winning long-term?

MarketBeat

How Is Becton, Dickinson and Company’s Performance Compared to Other Medical Instruments & Supplies Stocks?

Despite Becton, Dickinson and Company’s underperformance relative to its industry peers over the past year, Wall Street analysts maintain a moderately optimistic outlook on the stock’s prospects.

Barchart

Do Wall Street Analysts Like Intuitive Surgical Stock?

Intuitive Surgical has outperformed the broader market over the past year, and Wall Street analysts maintain a moderately optimistic outlook on the stock’s prospects.

Barchart

This Buy-Rated Robotics Stock Has an Unmatched Position

With several strong moats, Intuitive Surgical is trading at a discount to consensus price targets in 2025.

Barchart

Is Intuitive Surgical a Buy After Volatile Reaction to Earnings?

Despite beating on the top and bottom lines, tariff uncertainty makes the outlook for ISRG stock fluid; investors may want to wait for clarity before jumping in

MarketBeat

Get all your
news in one place.

100's of premium titles.
One news app.

Barchart

What to Expect From Intuitive Surgical’s Q1 2025 Earnings Report

Intuitive Surgical is set to announce its first-quarter results this month, with analysts forecasting double-digit growth in its bottom-line figure.

Barchart

Intuitive Surgical Stock: Is ISRG Outperforming the Healthcare Sector?

Intuitive Surgical's robust outperformance against the healthcare sector over the past year has reinforced Wall Street analysts' bullish outlook on the stock.

Barchart

Intuitive Surgical Stock Outlook: Is Wall Street Bullish or Bearish?

As Intuitive Surgical has outperformed the broader market over the past year, Wall Street analysts maintain a bullish outlook on the stock’s prospects.

Barchart

Citi Analysts Think This Robotic AI Stock Can Surge Another 25% From Here

This robotic AI stock is a “buy and hold” stock for the long term despite its lofty valuation.

Get all your
news in one place.

100's of premium titles.
One news app.

Barchart

Stocks Slip Before the Open With Focus on Trump’s WEF Remarks and Corporate Earnings

March S&P 500 E-Mini futures (ESH25) are down -0.20%, and March Nasdaq 100 E-Mini futures (NQH25) are down -0.49% this morning, taking a breather after a strong rally this week, with investors turning their attention to U.S. President Donald Trump’s speech at the World Economic Forum in Davos and a…

MarketBeat

Intuitive Surgical Leads the Pack in Robotic Surgery Innovation

The robotic-assisted surgery trend is accelerating and Intuitive Surgical continues to lead the pack as its continued to keeps its wide moat since 2000.

Barchart

Here's What to Expect From Intuitive Surgical's Next Earnings Report

Intuitive Surgical will release its fourth-quarter earnings later this month, and analysts anticipate a double-digit bottom-line growth.

Barchart

Is Hologic Stock Underperforming the Dow?

Hologic has lagged behind the Dow index over the past three months, yet analysts remain cautiously optimistic about the stock's growth potential.

MarketBeat

Top 3 Robotics and Automation Stocks for the Next AI Boom

The next wave of AI will include interactive and autonomous AI and these three companies are making inroads into these areas today

MarketBeat

2 Robotic Surgery Stocks Challenging Intuitive Surgical's Lead

Medtronic (MDT) and Zimmer Biomet (ZBH) are emerging as serious contenders in robotic surgery, challenging Intuitive Surgical’s (ISRG) market dominance.

Benzinga

Morgan Stanley Maintains Positive MedTech Outlook Despite Setbacks in 2024, Upgrades Intuitive Surgical And Stryker, Downgrades Nevro And Glaukos

Morgan Stanley upgrades key MedTech stocks, highlighting strong demand and growth potential, while downgrading others amid company-specific challenges.

1 2 3 4 5

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.